{"id":59625,"date":"2024-07-02T01:04:22","date_gmt":"2024-07-01T23:04:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/"},"modified":"2024-07-02T01:04:22","modified_gmt":"2024-07-01T23:04:22","slug":"afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/","title":{"rendered":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz"},"content":{"rendered":"<div>\n<p>NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;<b>Afya Limited (Nasdaq: AFYA; B3: A2FY34) (\u201cAfya\u201d or the \u201cCompany\u201d),<\/b> the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the Company on May 2<sup>nd<\/sup>, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participa\u00e7\u00f5es S.A., of 100% of the total share capital of Unidom Participa\u00e7\u00f5es S.A. (\u201cUnidompedro\u201d and \u201cFaculdade Dom Luiz\u201d), present in Salvador (BA), Luis Eduardo Magalh\u00e3es (BA), Barreiras (BA) and Ribeira do Pombal (BA).<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/5\/AF-LOGO-AFYA-POSITIVO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/5\/AF-LOGO-AFYA-POSITIVO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/21\/AF-LOGO-AFYA-POSITIVO.jpg\"><\/a><\/p>\n<p>\nThe acquisition contributes 300 operational medical school seats to Afya in Salvador, one of Brazil&#8217;s largest cities. The authorization request for these 300 seats was made to the Ministry of Education (&#8220;MEC&#8221;) before the Mais M\u00e9dicos\u00b4 Law was enacted and MEC concluded its analysis and issued Ordinance 630\/2020 (&#8220;Ordinance&#8221;) in 2020 to partially authorize the operation considering 125 medical seats. In 2021, as a result of a judicial order, MEC reviewed the Ordinance to authorize the 300 seats initially requested by Unidompedro. Said decision was confirmed by a judgment in 2023. Currently, Unidompedro has 300 seats authorized, of which 125 are final and 175 are subject to a final conclusion of the aforementioned court proceedings.<\/p>\n<p>\nThe aggregate purchase price was R$ 660.0 million, and the estimated Net Debt was deducted from the down payment. The price and payment conditions are:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nR$ 347.8 million, deducted from the estimated Net Debt, was paid in cash on the date hereof; and<\/li>\n<li>\nR$ 312.2 million will be paid in up to 10 annual installments of R$31.2 million, adjusted by the CDI (Interbank Certificate of Deposit) rate, and it is conditioned upon the maintenance of the authorization of the 175 seats in each of the prior year. The remaining payment balance is accelerated if a final and non-appealable conclusion of the aforementioned court proceedings, within the 10-year payment period, confirms the authorization for the 175 seats. In turn, if, within the same 10-year payment period, a final conclusion of the aforementioned court proceedings does not confirm the authorization for such 175 seats, the remaining payment balance will no longer be due.<\/li>\n<\/ul>\n<p>\nAfya expects an EV\/EBITDA of 4.2x at maturity and post synergies. 2024 projected Net Revenue for Unidom Participa\u00e7\u00f5es S.A. is R$ 110.5 million, of which around 88% is expected to come from the Medicine course. In 2027, at the medical school&#8217;s full maturity, the projected Net Revenue is R$ 267 million, which, over 95%, will come from Medicine.<\/p>\n<p>\nAdditionally, if Unidompedro or Faculdade Dom Luiz wins the bid processes in the Mais M\u00e9dicos 3 Program, an additional payment of R$250 thousand per granted seat will be made.<\/p>\n<p>\nFor more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.afya.com.br%2Fnews-events%2Fpresentations%2F&amp;esheet=54089832&amp;newsitemid=20240701889089&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.afya.com.br%2Fnews-events%2Fpresentations%2F&amp;index=1&amp;md5=c4972aee18552228a49e8b868a4ac24e\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.afya.com.br\/news-events\/presentations\/<\/a><\/p>\n<p>\n<strong>About Afya Limited (Nasdaq: AFYA, B3: A2FY34)<\/strong><\/p>\n<p>\nAfya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact:<\/b> <a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;&#111;&#x3a;&#105;&#x72;&#64;a&#x66;y&#x61;&#46;&#x63;&#111;&#x6d;&#46;&#x62;&#114;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x72;&#64;a&#x66;&#x79;&#x61;&#46;c&#x6f;&#x6d;&#x2e;&#98;r<\/a><br \/>I<b>R Website:<\/b> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.afya.com.br%2F&amp;esheet=54089832&amp;newsitemid=20240701889089&amp;lan=en-US&amp;anchor=ir.afya.com.br&amp;index=2&amp;md5=1f11587b001118e17d6a7e8e2a13b130\" rel=\"nofollow noopener\" shape=\"rect\">ir.afya.com.br<\/a><\/p>\n<p>\n<b>Media Contact:<\/b><br \/>C\u00edntia Moraes Marin<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;c&#x69;&#110;t&#x69;&#97;&#46;&#x6d;&#97;r&#x69;&#110;&#x40;&#x61;&#102;&#x79;&#x61;&#46;&#x63;&#111;m&#x2e;&#98;r\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#105;&#110;t&#x69;&#x61;&#46;m&#x61;&#x72;&#105;n&#x40;&#x61;&#102;y&#x61;&#x2e;&#99;o&#x6d;&#x2e;&#98;r<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (\u201cAfya\u201d or the \u201cCompany\u201d), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the Company on May 2nd, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participa\u00e7\u00f5es S.A., of 100% &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59625","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (\u201cAfya\u201d or the \u201cCompany\u201d), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the Company on May 2nd, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participa\u00e7\u00f5es S.A., of 100% ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-01T23:04:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz\",\"datePublished\":\"2024-07-01T23:04:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/\"},\"wordCount\":555,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240701889089\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/\",\"name\":\"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240701889089\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"datePublished\":\"2024-07-01T23:04:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240701889089\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240701889089\\\/en\\\/1927844\\\/22\\\/AF-LOGO-AFYA-POSITIVO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/","og_locale":"en_US","og_type":"article","og_title":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend","og_description":"NOVA LIMA, Brazil&#8211;(BUSINESS WIRE)&#8211;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (\u201cAfya\u201d or the \u201cCompany\u201d), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the Company on May 2nd, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participa\u00e7\u00f5es S.A., of 100% ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/","og_site_name":"Pharma Trend","article_published_time":"2024-07-01T23:04:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz","datePublished":"2024-07-01T23:04:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/"},"wordCount":555,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/","url":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/","name":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","datePublished":"2024-07-01T23:04:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240701889089\/en\/1927844\/22\/AF-LOGO-AFYA-POSITIVO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-announces-closing-of-the-acquisition-of-unidompedro-and-faculdade-dom-luiz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59625"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59625\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}